Medication Agents Associated With Increased Bruising or Bleeding Risk
For botulinum toxin injections, medications that inhibit coagulation or platelet function increase the risk of bruising and ecchymosis at injection sites. [1][2][3] For cosmetic botulinum toxin care, common pre-procedure medication restrictions focus on withholding nonessential antiplatelet and NSAID therapies and avoiding certain supplements that may inhibit clotting. [3][4][5]
Antiplatelet and Anticoagulant Medications
The following medication categories are commonly identified as increasing bruising risk after cosmetic botulinum toxin injections.
- Anticoagulants or “blood thinners” (examples include warfarin and dabigatran) [1][2]
- Antiplatelets (examples include aspirin and other aspirin-like products) [1][2]
- Nonsteroidal anti-inflammatory drugs (NSAIDs) (examples include ibuprofen and naproxen) [3][2]
Supplements Commonly Suggested to Avoid
The following supplements are commonly suggested to be avoided pre-procedure because they may impair clotting.
- Vitamin E [4]
- Omega-3 supplements [6]
- Gingko biloba [4][7]
Timing of Pre-Injection Avoidance Used in Practice Guidance
A dermatology review describing cosmetic injectables precautions recommends avoiding clot-inhibiting medications such as vitamin E, aspirin, and NSAIDs for 10–14 days prior to botulinum toxin treatment. [4]
Evidence-Based Injection-Related Considerations in Patients Taking Anticoagulants
A consensus statement for botulinum toxin A in anticoagulated patients with limb spasticity indicates injections should not be withheld solely because of anticoagulation, provided appropriate peri-procedural assessment is performed. [8] The consensus statement also provides an INR threshold for deep leg compartment muscle injections (INR ≤3.5) and recommends considering INR timing when there are concerns such as fluctuating INR or recent bleeding. [8]
Common Pitfalls to Avoid
- Discontinuation of anticoagulation or antiplatelet therapy without clinical coordination increases the risk of thrombotic events in patients with an indication for these drugs. [8]
- Holding only one agent while continuing other clot-inhibiting therapies may not reduce bruising risk adequately in procedural guidance that groups antiplatelet and NSAID effects together. [2][4]
Core Medication Avoidance List Used for Cosmetic Botulinum Toxin Preparation
- Aspirin-like antiplatelet therapy [2][4]
- NSAIDs (including ibuprofen and naproxen) [2][4]
- Anticoagulants (“blood thinners,” including warfarin and dabigatran) [1][2]
- Vitamin E [4]
- Omega-3 supplements [6]
- Gingko biloba [4]
Medication-Safety Clarification for Prescribing-Related Contraindications
The FDA BOTOX prescribing information includes counseling to disclose use of antiplatelets and anticoagulants before treatment. [1]